SEPT9 and SDC2 methylation levels were higher in 92.5% (37/40) and 97.5% (39/40) of cancer tissues than in their paired adjacent paracancerous tissues (P < .01, Figure 1A,B). This evidence concerns the gene SDC2 and cancer.